Interestingly, mice treated with valproic acid as a model of autism spectrum disorder have a decrease in cerebellar GSK3β phosphorylation, which was reversed by PGRN treatment in an Akt-dependent manner [30]. Here, GSK3B is linked to autism spectrum disorder.